Xencor Inc (XNCR)
19.02
+0.65
(+3.54%)
USD |
NASDAQ |
Apr 24, 16:00
19.04
+0.02
(+0.08%)
After-Hours: 20:00
Xencor Price to Book Value: 1.738 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.738 |
| April 23, 2024 | 1.679 |
| April 22, 2024 | 1.664 |
| April 19, 2024 | 1.680 |
| April 18, 2024 | 1.732 |
| April 17, 2024 | 1.743 |
| April 16, 2024 | 1.729 |
| April 15, 2024 | 1.838 |
| April 12, 2024 | 1.872 |
| April 11, 2024 | 1.875 |
| April 10, 2024 | 1.852 |
| April 09, 2024 | 1.969 |
| April 08, 2024 | 1.965 |
| April 05, 2024 | 1.946 |
| April 04, 2024 | 1.953 |
| April 03, 2024 | 1.967 |
| April 02, 2024 | 1.966 |
| April 01, 2024 | 2.003 |
| March 28, 2024 | 2.022 |
| March 27, 2024 | 2.049 |
| March 26, 2024 | 1.968 |
| March 25, 2024 | 2.001 |
| March 22, 2024 | 2.067 |
| March 21, 2024 | 2.085 |
| March 20, 2024 | 2.079 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.08 |
| March 18, 2024 | 2.033 |
| March 15, 2024 | 2.110 |
| March 14, 2024 | 2.013 |
| March 13, 2024 | 2.135 |
| March 12, 2024 | 2.084 |
| March 11, 2024 | 2.114 |
| March 08, 2024 | 2.216 |
| March 07, 2024 | 2.174 |
| March 06, 2024 | 2.178 |
| March 05, 2024 | 2.088 |
| March 04, 2024 | 2.186 |
| March 01, 2024 | 2.177 |
| February 29, 2024 | 2.097 |
| February 28, 2024 | 2.083 |
| February 27, 2024 | 2.424 |
| February 26, 2024 | 2.364 |
| February 23, 2024 | 2.236 |
| February 22, 2024 | 2.229 |
| February 21, 2024 | 2.202 |
| February 20, 2024 | 2.148 |
| February 16, 2024 | 2.207 |
| February 15, 2024 | 1.947 |
| February 14, 2024 | 1.833 |
| February 13, 2024 | 1.744 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.504
Minimum
Nov 09 2023
5.447
Maximum
Feb 08 2021
2.939
Average
2.898
Median
Jun 03 2019
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 16.00 |
| Karyopharm Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.706 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7198 |
Price to Book Value Related Metrics
| PS Ratio | 6.809 |
| PEG Ratio | -0.072 |
| Price to Free Cash Flow | 17.95 |
| Price | 19.02 |
| Earnings Yield | -11.04% |
| Market Cap | 1.163B |
| PEGY Ratio | -0.072 |